XML 30 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating Activities:    
Net Income (Loss) Attributable to Parent $ 23,401,000 $ (16,667,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities    
Depreciation 736,000 296,000
Inventory reserve 1,004,000 0
Non-cash interest expense 0 1,712,000
Write off of subscription receivable 379,000 0
Realized loss on debt extinguishment 14,104,000 0
Change in fair value of derivative instruments (18,498,000) 1,510,000
Change in fair value of earn-out interests liability (72,505,000) 0
Net realized (gains) losses on marketable debt securities, available-for-sale (1,000) 0
Stock-based compensation expense 1,658,000 12,000
Other non-cash items 364,000 (16,000)
Changes in operating assets and liabilities:    
Accounts receivable (2,973,000) (229,000)
Inventories (29,969,000) (297,000)
Prepaid expenses and other current assets (17,794,000) (41,000)
Other assets (506,000) 0
Accounts payable 9,009,000 (310,000)
Other current liabilities 2,696,000 1,692,000
Net cash used in operating activities (88,895,000) (12,338,000)
Investing Activities:    
Purchase of property and equipment (4,915,000) (407,000)
Purchases of marketable debt securities, available-for-sale (152,651,000) 0
Proceeds from sales and maturities of marketable debt securities, available-for-sale 2,423,000 0
Net cash used in investing activities (155,143,000) (407,000)
Financing Activities:    
Proceeds from reverse merger, net 20,721,000 0
Proceeds from PIPE investment 196,000,000 0
Proceeds from issuance of shares of Legacy Xos Preferred Stock 31,757,000 9,570,000
Proceeds from subscription receivable – preferred 2,430,000 0
Convertible notes payable - gross borrowings 0 13,440,000
Proceeds from exercise of Legacy Xos Preferred Stock warrant 2,715,000 0
Equipment loans payable - gross payments 0 190,000
Equipment loans payable - gross payments (444,000) (152,000)
Proceeds from stock option exercises 11,000 10,000
Taxes paid related to net share settlement of stock-based awards (335,000) 0
SAFEs - gross borrowings 0 30,000
Shares repurchased and retired 0 (3,000)
Net cash provided by financing activities 252,855,000 23,085,000
Net increase in cash, cash equivalents and restricted cash 8,817,000 10,340,000
Cash, cash equivalents and restricted cash, beginning of year 10,359,000 19,000
Cash, cash equivalents and restricted cash, end of year 19,176,000 10,359,000
Cash and cash equivalents 16,142,000 10,359,000
Restricted cash 3,034,000 0
Total cash, cash equivalents and restricted cash 19,176,000 10,359,000
Supplemental disclosure of non-cash financing activities    
Conversion of interest payable on convertible notes 2,453,000 0
Fair value adjustment of related party debt at conversion 3,763,000 0
Issuance of Legacy Xos Preferred Stock, incl. note conversion 34,918,000 0
Conversion of notes payable into Legacy Xos Preferred Stock 21,540,000 0
Conversion of Legacy Xos Preferred Stock into Common Stock 79,708,000 0
Assumption of Public Warrants and Private Placement Warrants 17,891,000 0
Recognition of Earn-out Shares liability 101,744,000 0
Transaction costs relating to the reverse merger offset against additional paid-in capital 55,424,000 0
Redeemable warrant issued for redeemable convertible preferred shares 0 1,707,000
Redeemable convertible preferred shares issued and stock options exercised for subscription receivable $ 0 $ 2,446,000